OK Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 11, 2022
Share
OK Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 417.13 million compared to TWD 295.95 million a year ago. Net income was TWD 48.71 million compared to TWD 29.76 million a year ago. Basic earnings per share from continuing operations was TWD 0.52 compared to TWD 0.32 a year ago. Diluted earnings per share from continuing operations was TWD 0.44 compared to TWD 0.3 a year ago. Basic earnings per share was TWD 0.52 compared to TWD 0.32 a year ago. Diluted earnings per share was TWD 0.44 compared to TWD 0.3 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
